Characteristics and Outcome of COVID-19 in Patients with Relapsing Multiple Sclerosis Receiving Ofatumumab

被引：0
|
作者：
Cross, Anne H. [1 ]
Delgado, Silvia [2 ]
Habek, Mario [3 ]
Davydovskaya, Maria [4 ]
Totolyan, Natalia [5 ]
Pingili, Ratnakar [6 ]
Mancione, Linda [6 ]
Sullivan, Roseanne [6 ]
Zalesak, Martin [7 ]
Su, Wendy [6 ]
Ramanathan, Krishnan [7 ]
Montalban, Xavier [8 ]
Winthrop, Kevin [9 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[3] Univ Zagreb, Univ Hosp Ctr Zagreb, Sch Med, Zagreb, Croatia
[4] Moscow State Publ Healthcare InsC Clin Hosp 24, Moscow, Russia
[5] Natl Med Univ, St Petersburg, Russia
[6] Novartis Pharmaceut, E Hanover, NJ USA
[7] Novartis Pharma AG, Basel, Switzerland
[8] Hosp Univ Vall dHebron, Dept Neurol Neuroimmunol, Ctr Esclerosi Multiple Catalunya Cemcat, Barcelona, Spain
[9] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
4123
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Outcomes of COVID-19 in patients with relapsing multiple sclerosis receiving ofatumumab: data from the ALITHIOS study and post marketing surveillance
    Cross, A. H.
    Delgado, S.
    Habek, M.
    Davydovskaya, M.
    Ward, B. J.
    Cree, B. A. C.
    Totolyan, N.
    Pingili, R.
    Mancione, L.
    Sullivan, R.
    Su, W.
    Zielman, R.
    Das Gupta, A.
    Montalban, X.
    Winthrop, K.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 797 - 798
  • [2] COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab
    Anne H. Cross
    Silvia Delgado
    Mario Habek
    Maria Davydovskaya
    Brian J. Ward
    Bruce A. C. Cree
    Natalia Totolyan
    Ratnakar Pingili
    Linda Mancione
    Xixi Hu
    Roseanne Sullivan
    Wendy Su
    Ronald Zielman
    Ayan Das Gupta
    Xavier Montalban
    Kevin Winthrop
    [J]. Neurology and Therapy, 2022, 11 : 741 - 758
  • [3] COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab
    Cross, Anne H.
    Delgado, Silvia
    Habek, Mario
    Davydovskaya, Maria
    Ward, Brian J.
    Cree, Bruce A. C.
    Totolyan, Natalia
    Pingili, Ratnakar
    Mancione, Linda
    Hu, Xixi
    Sullivan, Roseanne
    Su, Wendy
    Zielman, Ronald
    Das Gupta, Ayan
    Montalban, Xavier
    Winthrop, Kevin
    [J]. NEUROLOGY AND THERAPY, 2022, 11 (02) : 741 - 758
  • [4] Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumab
    Hendin, B. A.
    Cross, A. H.
    Chinea, A. R.
    Tullman, M. J.
    Aburashed, R.
    Stankiewicz, J.
    Lucassen, E.
    Meng, X.
    Bar-Or, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 367 - 367
  • [5] Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumab
    Bar-Or, Amit
    Aburashed, Rany
    Chinea, Angel R.
    Hendin, Barry A.
    Lucassen, Elisabeth
    Meng, Xiangyi
    Stankiewicz, James
    Tullman, Mark J.
    Cross, Anne H.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
  • [6] Characteristics of COVID-19 in patients with multiple sclerosis
    Ghadiri, Fereshteh
    Sahraian, Mohammad Ali
    Shaygannejad, Vahid
    Ashtari, Fereshteh
    Langroodi, Hamidreza Ghalyanchi
    Baghbanian, Seyed Mohammad
    Mozhdehipanah, Hossein
    Majdi-Nasab, Nastaran
    Hosseini, Samaneh
    Poursadeghfard, Maryam
    Beladimoghadam, Nahid
    Razazian, Nazanin
    Ayoubi, Saeideh
    Rezaeimanesh, Nasim
    Eskandarieh, Sharareh
    Moghadasi, Abdorreza Naser
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 57
  • [7] Outcome of COVID-19 infection in multiple sclerosis patients receiving disease-modifying therapies
    Etemadifar, Masoud
    Sami, Ramin
    Salari, Mehri
    Sedaghat, Nahad
    Sigari, Amirhossein Akhavan
    Aghababaei, Ali
    Najafi, Mohammadreza
    Tehrani, Donya Sheibani
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2021, 26 (01):
  • [8] Characteristics of COVID-19 disease in multiple sclerosis patients
    Barzegar, Mahdi
    Mirmosayyeb, Omid
    Ghajarzadeh, Mahsa
    Nehzat, Nasim
    Vaheb, Saeed
    Shaygannejad, Vahid
    Vosoughi, Reza
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 45
  • [9] Ofatumumab for relapsing forms of multiple sclerosis
    Gajofatto, Alberto
    Orlandi, Riccardo
    [J]. DRUGS OF TODAY, 2022, 58 (01) : 9 - 21
  • [10] Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
    Onder, Halil
    [J]. TURKISH JOURNAL OF NEUROLOGY, 2019, 25 (02) : 105 - 106
12345